Last updated: May 23, 2026
Who supplies TOPICORT (desoxymethasone) and what supply chain labels matter?
Answer: TOPICORT is an OTC and Rx topical corticosteroid product sold in the US under the brand name TOPICORT by Perrigo (commonly listed as the marketed holder on labeling and FDA records). The “supplier” for drug product supply typically breaks into (1) labeler/market authorization holder, (2) finished dosage form manufacturer(s), and (3) API and key excipient suppliers. The only supply-chain mapping that can be treated as reliable for regulatory and litigation use is what is stated in FDA labeling (NDC labeler), FDA application listings, and Orange Book/RLD sourcing records, not internet distributor listings.
What “supplier” means in regulatory terms
- Labeler (NDC “labeler”): the entity appearing on the product label/NDC directory. This is the party most consistently traceable for commercial transactions and FDA submissions.
- Manufacturing site (finished dosage form): the entity that actually fills and packages the cream/ointment.
- API source: the company manufacturing desoxymethasone (and any intermediate).
- Excipients and packaging: suppliers for base components (petrolatum/emollients, emulsifiers) and tube/jar packaging.
What is TOPICORT’s FDA product identity (strength, dosage forms, labeler) for supplier verification?
Answer: TOPICORT is marketed as desoxymethasone topical corticosteroid in cream and ointment dosage forms. For supplier due diligence, the critical starting point is the NDC labeler shown on the specific strength/dosage form. A supplier change can occur at the finished-dosage manufacturing level while the labeler remains constant.
Key verification checklist for supply sourcing
- Match the exact strength and dosage form (cream vs ointment).
- Use the specific NDC to determine the labeler and the application referenced for that NDC.
- Pull the FDA label for the NDC and confirm the labeled manufacturer/distributor line.
- Cross-check with Orange Book if the product is listed with a reference drug (for prescription variants and listed patent coverage).
- For commercial supply, align with DMF/API references only when explicitly tied to the NDC labeling record.
What companies manufacture desoxymethasone topical products like TOPICORT?
Answer: Desoxymethasone API and desoxymethasone topical formulations are supplied by multiple manufacturers globally, but the only defensible “supplier” list for TOPICORT itself is the set of entities named on the finished product label (manufacturer/distributor statement for each NDC). Without those NDC-specific label records and FDA application tables for TOPICORT’s current lineup, any named manufacturer list would be non-auditable.
How do you identify the correct TOPICORT finished drug product manufacturer(s)?
Answer: The practical way to identify finished product suppliers is to use NDC-to-label mappings and FDA listing data for the specific dosage form.
Manufacturer identification workflow used in procurement and compliance
- Step 1: Determine the exact NDC for the cream and ointment strength used in your market.
- Step 2: Read the “Manufactured for” / “Distributed by” / “Manufactured by” lines on the FDA-approved labeling for that NDC.
- Step 3: Map the labeled manufacturer to procurement terms (license holder vs contract manufacturer).
- Step 4: If multiple NDCs exist for the same brand name, repeat the process for each NDC.
What are the main risks if the “supplier” changes for TOPICORT?
Answer: The supply risk is usually at the finished-dosage manufacturing level, not the labeler level, and it affects quality and regulatory continuity.
Risk areas procurement teams flag
- Site change affecting packaging configuration, tube material, or batch record processes.
- Implied formulation variability between cream and ointment bases that can shift physical attributes.
- API sourcing continuity if desoxymethasone supply constraints occur upstream.
- Lot traceability and ability to support QA investigations for OOS/OOT events.
What sources should you use to map TOPICORT suppliers for audits and regulatory filings?
Answer: Use only primary regulatory datasets and product-label records.
Primary sources that support supplier mapping
- FDA NDC directory and label information for the exact NDC
- FDA product labeling for the NDC (manufacturer/distributor statements)
- Orange Book entries if TOPICORT is listed for the relevant NDA and dosage form
- FDA Drugs@FDA for approval history tied to the application referenced by that NDC
Who supplies competing desoxymethasone topical corticosteroids (and why that matters)?
Answer: For competitive or shortage planning, teams map suppliers for competing topical desoxymethasone brands and authorized generics by the same NDC-to-label and FDA listing method. This avoids incorrect assumptions from distributor catalogs that do not show the labeled manufacturer.
Supplier comparison approach for competitive substitution
- Compare NDC labelers, dosage forms, and strengths
- Verify finished product manufacturer on labeling
- Confirm regulatory status and whether substitution is considered equivalent (same active and same dosage form)
Key Takeaways
- The only supplier list that is actionable for TOPICORT procurement and compliance is the set of entities stated in NDC-specific labeling and FDA listing data.
- “Supplier” must be separated into labeler, finished dosage form manufacturer, and API/excipient sources; most supply disruption risk is at the finished-manufacturer and packaging level.
- Supplier mapping should be performed by NDC and dosage form to prevent errors across strength or cream vs ointment variants.
- For audit-ready answers, rely on FDA NDC/label records and FDA listing datasets rather than generic distributor websites.
FAQs
-
How can I confirm the finished drug manufacturer of TOPICORT for a specific NDC?
Use the NDC-specific FDA label lines that state “Manufactured by” or “Manufactured for/Distributed by.”
-
Does TOPICORT’s labeler ever stay the same when the manufacturing site changes?
It can; packaging and manufacturing contracts can change without changing the market authorization holder.
-
How do I distinguish TOPICORT cream suppliers from TOPICORT ointment suppliers?
Map each to its separate NDC and read the labeled manufacturer/distributor statements for each dosage form.
-
What data sources are best for TOPICORT supplier due diligence in the US?
FDA NDC directory, FDA labeling for the NDC, Drugs@FDA, and Orange Book where applicable.
-
What upstream supplier risks affect desoxymethasone topical products during shortages?
API supply constraints and excipient/packaging availability typically drive lead times, which then cascade to finished-dosage contract manufacturing.
References
- FDA. “NDC Directory.” U.S. Food and Drug Administration.
- FDA. “Drugs@FDA.” U.S. Food and Drug Administration.
- FDA. “Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations.” U.S. Food and Drug Administration.
- FDA. “Drug Label Information for Prescription Products.” U.S. Food and Drug Administration.
